Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penfluridol versus olanzapine or risperidone for psychotic disorders
NL-OMON26965Suspended
- Sponsor
- Erasmus MC
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Schizophrenia Spectrum Disorders (SSD), schizophrenia, schizoaffective disorder and 2 more comparing Penfluridol once weekly, Olanzapine once daily and Risperidone once daily (3 arms). Primary endpoint: Time to all-cause medication discontinuation. Started Jan 2017; status: suspended.
02
Drugs
penfluridololanzapinerisperidone
03
Conditions
Schizophrenia Spectrum Disorders (SSD)schizophreniaschizoaffective disorderdelusional disorderUnspecified psychosis
Beyond the preview
Go deeper on NL-OMON26965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26965.